Who
Lishan Aklog
Chairman and CEO
Company insider
Files Form 4 as: Chairman and CEO, PAVmed; Chief Executive Officer, Lucid Diagnostics; Director, Contrafect; Director, Viveon Health Acquisition.
In numbers
- Trades disclosed
- 60
- Buys
- 14
- Sells
- 0
- Bought
- $107K
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 17 May 2016
- Last trade
- 2 Apr 2026
- Last filed
- 3 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Apr 2026filed 3 Apr 2026 | PAVM PAVmedMedical Devices | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 2 Apr 2026filed 3 Apr 2026 | PAVM PAVmedMedical Devices | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —2,170,000 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —2,170,000 at $0.00 | filing |
| 30 Sep 2025filed 2 Oct 2025 | PAVM PAVmedMedical Devices | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 20 Feb 2025filed 21 Feb 2025 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 7 May 2024filed 8 May 2024 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 17 May 2022filed 18 May 2022 | Contrafectoption or derivative | SEC FORM 4 Code A | $141K42,000 at $3.35 | filing |
| 28 Mar 2022filed 11 Apr 2022 | PAVM PAVmedMedical Devices | SEC FORM 4 Code F | $94K79,636 at $1.18 | filing |
| 18 Feb 2022filed 23 Feb 2022 | PAVM PAVmedoption or derivative · Medical Devices | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 18 Feb 2022filed 23 Feb 2022 | LUCD Lucid Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 7 Jan 2022filed 10 Jan 2022 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 18 May 2021filed 20 May 2021 | Contrafectoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 1 Apr 2021filed 5 Apr 2021 | PAVM PAVmedMedical Devices | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 18 Mar 2021filed 19 Mar 2021 | PAVM PAVmedMedical Devices | SEC FORM 4 Bought | $32K7,500 at $4.31 | filing |
| 23 Dec 2020filed 28 Dec 2020 | Viveon Health Acquisition | SEC FORM 4 Code J | —27,000 at $0.00 | filing |
| 15 Jun 2020filed 17 Jun 2020 | Contrafectoption or derivative | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 30 Apr 2020filed 4 May 2020 | PAVM PAVmedMedical Devices | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 23 May 2019filed 28 May 2019 | PAVM PAVmedMedical Devices | SEC FORM 4 Bought | $33K30,000 at $1.10 | filing |
| 15 Mar 2019filed 19 Mar 2019 | PAVM PAVmedMedical Devices | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.